Brzezinka, Krzysztof
Nevedomskaya, Ekaterina
Lesche, Ralf
Steckel, Michael
Eheim, Ashley L.
Haegebarth, Andrea
Stresemann, Carlo
Article History
Received: 29 March 2019
Accepted: 5 June 2019
First Online: 28 June 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable<b>.</b>
: All authors are employees of Bayer AG. C.S. is listed as inventor of a patent application (WO2017207387A1) related to Menin-MLL inhibitors.